ANNOUNCEMENT

Take a look at the MedCity ENGAGE program, with expert speakers from leading organizations. Reserve your place today.

Topic: AstraZeneca

AstraZeneca needs new new products as others lose patent protection, accelerates drug pipeline

AstraZeneca needs new new products as others lose patent protection, accelerates drug pipeline

May 16, 2013 6:10 am by | 0 Comments

LONDON (Reuters) - AstraZeneca has enrolled the first patient into a final-stage clinical trial of a new drug for a rare type of leukemia as the group's new CEO delivers ... Read more
AstraZeneca gets U.S. subpoena over UK drug factory

AstraZeneca gets U.S. subpoena over UK drug factory

April 25, 2013 5:30 am by | 0 Comments

LONDON (Reuters) - AstraZeneca said on Thursday it had received a subpoena from the U.S. Attorney's Office in Boston, Massachusetts, related to manufacturing standards at its Macclesfield facility in the ... Read more
AstraZeneca Q1 sales tumble as generic losses bite deep

AstraZeneca Q1 sales tumble as generic losses bite deep

April 25, 2013 2:11 am by | 0 Comments

LONDON, April 25 (Reuters) - AstraZeneca's sales fell by a bigger-than-expected 13 percent in the first quarter as patent expiries sent revenue from key medicines skidding lower, underscoring the turnaround ... Read more
AstraZeneca arthritis drug has mixed results in Phase III trial

AstraZeneca arthritis drug has mixed results in Phase III trial

April 5, 2013 2:21 am by | 0 Comments

LONDON (Reuters) - AstraZeneca's experimental rheumatoid arthritis pill fostamatinib produced mixed results in a late-stage clinical trial, the company said on Friday.It achieved a statistically significant improvement in a test ... Read more
AstraZeneca suffers fresh drug patent setback in U.S.

AstraZeneca suffers fresh drug patent setback in U.S.

April 2, 2013 2:50 am by | 0 Comments

LONDON (Reuters) - AstraZeneca has suffered a fresh patent setback with a U.S. court decision that a patent protecting its Pulmicort Repsules asthma treatment is invalid, clearing the way for ... Read more
Diabetes drugs tied to pancreatitis: study

Diabetes drugs tied to pancreatitis: study

February 28, 2013 4:05 pm by | 1 Comments

NEW YORK (Reuters Health) - People who take a certain type of diabetes drug to lower blood sugar levels may be at an increased risk of developing an inflamed pancreas, ... Read more

Flu vaccine worked in just over half of Americans who got it

Flu vaccine worked in just over half of Americans who got it

February 21, 2013 2:14 pm by | 3 Comments

CHICAGO (Reuters) - A U.S. government analysis of this season's flu vaccine suggests it was effective in only 56 percent of people who got the shot, and it completely failed ... Read more
As profits fall, new AstraZeneca CEO hints at more changes

As profits fall, new AstraZeneca CEO hints at more changes

February 1, 2013 5:45 am by | 0 Comments

Pascal Soriot started as chief executive officer of AstraZeneca on Oct. 1. He has already made top-level management changes and his early observations might foreshadow more shifting in how the ... Read more
UK cost agency rejects drugs from AstraZeneca, Bristol and Roche

UK cost agency rejects drugs from AstraZeneca, Bristol and Roche

January 31, 2013 7:32 pm by | 0 Comments

LONDON (Reuters) - Britain's healthcare cost watchdog NICE said on Friday it was not able to recommend a new diabetes drug from Bristol-Myers Squibb and AstraZeneca, and has asked for ... Read more
AstraZeneca’s pill for RA can’t outperform Humira in study

AstraZeneca’s pill for RA can’t outperform Humira in study

December 13, 2012 2:49 am by | 0 Comments

LONDON (Reuters) - An experimental rheumatoid arthritis drug from AstraZeneca proved inferior to Abbott Laboratories' Humira in a clinical study, knocking hopes for one of the few late-stage products in ... Read more
Indian board rejects AstraZeneca’s patent plea on cancer drug

Indian board rejects AstraZeneca’s patent plea on cancer drug

November 28, 2012 1:13 am by | 0 Comments

(Reuters) - India's patents appeal board has dismissed British drugmaker AstraZeneca's petition challenging an earlier ruling that refused patent protection for a cancer-fighting drug, in the latest blow for Big ... Read more
MedImmune creating drug pipeline for AstraZeneca

MedImmune creating drug pipeline for AstraZeneca

November 18, 2012 4:56 pm by | 0 Comments

MedImmune leaders say they are entering a prime phase in drug development, with several projects moving into final patient trials and a growing share of AstraZeneca's overall drug pipeline. Given ... Read more
EU approves Bristol-Astra diabetes drug Forxiga after FDA rejection due to cancer risk

EU approves Bristol-Astra diabetes drug Forxiga after FDA rejection due to cancer risk

November 14, 2012 2:43 pm by | 1 Comments

Nov 14 (Reuters) - European regulators have approved the first in a new class of diabetes medicines that work independently of insulin to control blood sugar, the drug's developers Bristol-Myers ... Read more
New CEO has work cut out as AstraZeneca sales fall 19% in Q3

New CEO has work cut out as AstraZeneca sales fall 19% in Q3

October 25, 2012 2:58 am by | 0 Comments

LONDON (Reuters) - AstraZeneca's sales slumped by a bigger-than-expected 19 percent in the third quarter, underscoring the challenges confronting the drugmaker's new chief executive, Pascal Soriot.Faced with patent expiries on ... Read more
AstraZeneca, Ironwood will bring irritable bowel syndrome treatment to China

AstraZeneca, Ironwood will bring irritable bowel syndrome treatment to China

October 23, 2012 9:13 am by | 0 Comments

AstraZeneca and Ironwood Pharmaceuticals (NASDAQ: IRWD) announced today an agreement to co-develop and co-commercialize Ironwood's linaclotide in China. Linaclotide is the first and only guanylate cyclase-C (GC-C) agonist approved by ... Read more